These data demonstrate that stimulation of FGF23 production by LCN2 in osteoblasts is mediated at least in part by cAMP signaling and that LCN2 and FGF23 are part of a vicious cycle in CKD (Fig. 6i). This evidence concerns the gene FGF23 and chronic kidney disease.